Because MOG is expressed on the surface of the myelin sheath, it is presumed to be easily accessible to antibodies, cells, and other immune system components and has been studied for years as a potential autoimmune target in multiple sclerosis (MS) and other autoimmune neurologic diseases. Here, MOG is linked to myeloid sarcoma.